Author:
Anastasilakis A. D.,Polyzos S. A.,Gkiomisi A.,Saridakis Z. G.,Digkas D.,Bisbinas I.,Sakellariou G. T.,Papatheodorou A.,Kokkoris P.,Makras P.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism
Reference23 articles.
1. Nancollas GH, Tang R, Phipps RJ, Henneman Z, Gulde S, Wu W, Mangood A, Russell RG, Ebetino FH (2006) Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. Bone 38:617–627
2. Cummings SR, San Martin J, McClung MR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756–765
3. Black DM, Delmas PD, Eastell R et al (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809–1822
4. Stolina M, Dwyer D, Middleton S, Adamu S, Ominsky MS, Zack D, Kostenuik PJ (2007) OPG prevents osteopenia in arthritic rats via different mechanisms than bisphosphonate therapy. J Bone Miner Res 22(Suppl 1):S475
5. Baron R, Ferrari S, Russell RG (2011) Denosumab and bisphosphonates: different mechanisms of action and effects. Bone 48:677–692
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献